ICER Recommendations Can Be Influenced With the Right Evidence

November 19, 2020

Based on previous ICER reports, when a pharma product goes through an ICER assessment, there is an extremely high chance that the manufacturer will face a price cut recommendation, and almost half the time the recommended reduction will be greater than 60%.

Challenging ICER evaluations is difficult but leveraging an independent evaluation can produce the evidence which ultimately leads to changes within ICER’s final reports. With evidence from ICER’s assessments factoring more and more into final pricing decisions, a negative review can put your organization at risk – doing everything you can to get an accurate evaluation is more important than ever. To learn more about how you can best prepare for an ICER evaluation, reach out to Panalgo at modelingandstrategy@panalgo.com.

Read more here.

Share This Story!